000 01306 a2200361 4500
005 20250516135241.0
264 0 _c20131219
008 201312s 0 0 eng d
022 _a1745-7262
024 7 _a10.1038/aja.2012.166
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGray, Phillip J
245 0 0 _aThe opportunity cost of androgen suppression in locally advanced prostate cancer.
_h[electronic resource]
260 _bAsian journal of andrology
_cMay 2013
300 _a356-7 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aAdenocarcinoma
_xtherapy
650 0 4 _aAndrogen Antagonists
_xtherapeutic use
650 0 4 _aAntineoplastic Agents, Hormonal
_xtherapeutic use
650 0 4 _aBone Density Conservation Agents
_xtherapeutic use
650 0 4 _aBrachytherapy
650 0 4 _aDiphosphonates
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImidazoles
_xtherapeutic use
650 0 4 _aLeuprolide
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aProstatic Neoplasms
_xtherapy
650 0 4 _aQuality of Life
700 1 _aEfstathiou, Jason A
700 1 _aShipley, William U
773 0 _tAsian journal of andrology
_gvol. 15
_gno. 3
_gp. 356-7
856 4 0 _uhttps://doi.org/10.1038/aja.2012.166
_zAvailable from publisher's website
999 _c22529235
_d22529235